v3.26.1
Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)
 3 Months Ended
Mar. 31, 2026
USD ($)
segment
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Cash and cash equivalents $ 18,519,784 $ 10,329,967 $ 24,711,356
Working capital 500,000    
Deferred grant funding 18,150,459   19,651,452
Accumulated deficit (191,688,793)   (188,688,904)
Net income (loss) (2,999,889) (4,378,307)  
cash flow operations $ (5,500,000)    
Number of operating segments | segment 1    
Number of reportable segments | segment 1    
Total revenue $ 152,455 25,427  
Outstanding advances 1,800,000    
Other receivables     $ 400,000
Restricted cash included in other non-current assets 300,000 $ 300,000  
Other Receivables, Current      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Outstanding advances 400,000    
Other Noncurrent Assets      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Outstanding advances 1,400,000    
Preeclampsia Agreement      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Total revenue 499,000    
Contraceptive Landscape Review Agreement      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Transaction price allocated to remaining performance obligations 300,000    
Research And Development Services      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Total revenue $ 200,000    
Minimum      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Indirect cost allowance percentage 5.00%    
Repayment period on outstanding advances 2 years    
Maximum      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Indirect cost allowance percentage 22.00%    
Repayment period on outstanding advances 4 years